Related content

MDM2 Splice Variants and Their Therapeutic Implications

By  

Current Cancer Drug Targets, Vol. 5, Iss. 1, 2005-02 ,pp. : 21-26

Bentham Science Publishers

Access to resources Recommend Favorite

Dopamine DA 1 Receptor Agonist Activity of YM435 in the Canine Renal Vasculature

By Yatsu T.   Uchida W.   Inagaki O.   Tanaka A.   Takenaka T.  

General Pharmacology, Vol. 29, Iss. 2, 1997-08 ,pp. : 229-232

Elsevier

Access to resources Recommend Favorite

Dopamine D₂ receptor-dependent modulation of striatal NO synthase activity

By Sammut Stephen   Bray Kristina   West Anthony  

Psychopharmacology, Vol. 191, Iss. 3, 2007-04 ,pp. : 793-803

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacological Survey of Medicinal Plants for Activity at Dopamine Receptor Subtypes. II. Screen for Binding Activity at the D1 and D2 Dopamine Receptor Subtypes

By Luedtke Robert R.   Freeman Rebekah A.   Volk Michael   Arfan Mohammad   Reinecke Manfred G.  

Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol. 41, Iss. 1, 2003-02 ,pp. : 45-58

Informa Healthcare

Access to resources Recommend Favorite

Pasternak and Standifer reply - The KOR3 receptor and the 3 -opioid receptor may be splice variants of the same gene

By Pasternak G.W.   Standifer K.M.  

Trends in Pharmacological Sciences, Vol. 17, Iss. 6, 1996-06 ,pp. : 217-218

Elsevier

Access to resources Recommend Favorite